Inhibition of IGFBP-2 improves the sensitivity of bladder cancer cells to cisplatin via upregulating the expression of maspin

Author：        

Publisher： Spandidos Publications

E-ISSN： 1791-244X|36|2|595-601

ISSN： 1107-3756

Source： International Journal of Molecular Medicine, Vol.36, Iss.2, 2015-01, pp. : 595-601

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Sodium‐glucose cotransporter‐2 inhibition improves incretin sensitivity of pancreatic β‐cells in people with type 2 diabetes

By  

DIABETES OBESITY & METABOLISM (ELECTRONIC), Vol. 20, Iss. 2, 2018-02 ,pp. : 370-377

John Wiley & Sons Inc

Access to resources Recommend Favorite

Additional Gene Therapy with rAAV-wt-p53 Enhanced the Efficacy of Cisplatin in Human Bladder Cancer Cells

By  

Urologia Internationalis, Vol. 77, Iss. 4, 2006-11 ,pp. : 355-361

Karger

Access to resources Recommend Favorite

Insilico inhibition of hexokinase-2 to treat cancer cells

By Subhashini R.  

International Journal of Medical Engineering and Informatics, Vol. 5, Iss. 1, 2013-01 ,pp. : 1-4

Inderscience Publishers

Access to resources Recommend Favorite

Gemcitabine plus Cisplatin in Adjuvant Regimen for Bladder Cancer

By  

Urologia Internationalis, Vol. 71, Iss. 1, 2003-07 ,pp. : 37-40

Karger

Access to resources Recommend Favorite

Bladder Cancer and Stem Cells

By  

Current Signal Transduction Therapy, Vol. 7, Iss. 3, 2012-09 ,pp. : 209-219

Bentham Science Publishers

Access to resources Recommend Favorite